Casper Sleep has slashed its valuation ahead of its IPO, which is unsurprising given the firm loses money. Heap on the regulatory scrutiny of M&A deals, and existing investors are in for some restless nights, writes jennifersaba.
Casper Sleep on Feb. 5 reduced the price range for its initial public offering to $12 to $13 a share from an earlier $17 to $19 a share. The online mattress firm hopes to sell 9.6 million shares including the so-called greenshoe option that allows underwriters to sell up to an additional 15% of stock once the initial deal is complete.
At the top end of the range Casper would raise $124.8 million and have a valuation of $531.7 million.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Casper cuts expected IPO price range to $12-$13 a share from $17-$19 a shareCasper Sleep disclosed in a government filing that it would cut its initial public offering price to a range between $12 and $13 per share.
Read more »
Casper Sleep lowers IPO price range, implying valuation of just over $500 millionCasper Sleep Inc. lowered the price range for its planned initial public offering on Wednesday to $12 to $13 a share from a previous $17 to $19, a move that...
Read more »
Casper Sleep slashes the price range for its planned IPO - Business InsiderIt's a fraction of the $1.1 billion valuation private markets gave Casper in its last funding round.
Read more »
Casper Slashes IPO Price Range, Lowering Its Valuation To Around $500 MillionSeveral early investors stand to lose money after the mattress company lowered expectations around its IPO.
Read more »
Casper Slashes IPO Price Range, Lowering Its Valuation To Around $500 MillionOnline mattress startup Casper slashes IPO price range, lowering its valuation to around $500 million by skleb1234
Read more »
Breakingviews TV: Casper IPO | Reuters VideoThe online mattress firm slashed its valuation by another 30% ahead of its stock-market debut. M&A options may get kicked out of bed, too, given regulatory scrutiny of the deal for shaving startup Harry’s. Jennifer Saba explains why this doesn’t bode well for investors.
Read more »